CN114617169A - 一种预防和降低高血压、血糖和血脂的奶粉 - Google Patents
一种预防和降低高血压、血糖和血脂的奶粉 Download PDFInfo
- Publication number
- CN114617169A CN114617169A CN202011462379.XA CN202011462379A CN114617169A CN 114617169 A CN114617169 A CN 114617169A CN 202011462379 A CN202011462379 A CN 202011462379A CN 114617169 A CN114617169 A CN 114617169A
- Authority
- CN
- China
- Prior art keywords
- powder
- vitamin
- parts
- preventing
- milk powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 161
- 210000004369 blood Anatomy 0.000 title claims abstract description 38
- 239000008280 blood Substances 0.000 title claims abstract description 38
- 235000013336 milk Nutrition 0.000 title claims abstract description 36
- 239000008267 milk Substances 0.000 title claims abstract description 36
- 210000004080 milk Anatomy 0.000 title claims abstract description 36
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 18
- 235000000832 Ayote Nutrition 0.000 claims abstract description 23
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 23
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 23
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 23
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 23
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 23
- 244000302512 Momordica charantia Species 0.000 claims abstract description 23
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 23
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 23
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 23
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 18
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 18
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 18
- 239000005862 Whey Substances 0.000 claims abstract description 18
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 18
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 235000019198 oils Nutrition 0.000 claims abstract description 13
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- -1 compound vitamin Chemical class 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000021323 fish oil Nutrition 0.000 claims abstract description 10
- 229910052742 iron Inorganic materials 0.000 claims abstract description 10
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 9
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 9
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 9
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 9
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 9
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 9
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 8
- 239000011710 vitamin D Substances 0.000 claims abstract description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- 229940046008 vitamin d Drugs 0.000 claims abstract description 8
- 239000011701 zinc Substances 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 6
- 229940075999 phytosterol ester Drugs 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 6
- 239000007787 solid Substances 0.000 claims description 26
- 235000013361 beverage Nutrition 0.000 claims description 25
- 240000001980 Cucurbita pepo Species 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 5
- 230000035622 drinking Effects 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 235000002378 plant sterols Nutrition 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000011575 calcium Substances 0.000 abstract description 5
- 229910052791 calcium Inorganic materials 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 235000019789 appetite Nutrition 0.000 abstract description 2
- 230000036528 appetite Effects 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 230000037182 bone density Effects 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract description 2
- 210000003743 erythrocyte Anatomy 0.000 abstract description 2
- 230000011132 hemopoiesis Effects 0.000 abstract description 2
- 210000004400 mucous membrane Anatomy 0.000 abstract description 2
- 240000004244 Cucurbita moschata Species 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 11
- 235000007106 Crataegus suborbiculata Nutrition 0.000 description 4
- 241000073432 Crataegus suborbiculata Species 0.000 description 4
- 235000013202 a hawthorn Nutrition 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 230000009102 absorption Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种预防和降低高血压、血糖和血脂的奶粉，包含如下原料组成：脱脂乳粉、高油乳清粉、低聚异麦芽糖、碳酸钙、粉末植物甾醇酯、复配维生素、牛磺酸、复配矿物质、Bb‑12动物双歧杆菌、鱼油粉、苦瓜粉、枸杞粉、山楂粉、南瓜粉、山药粉以及乳铁蛋白；本发明蛋白质是人体的主要构成物质并提供多种氨基酸；维生素A有助于维持皮肤和黏膜健康；维生素D可促进钙的吸收；维生素E有抗氧化作用；维生素C可以促进铁的吸收；钙是骨骼和牙齿的主要成分，并维持骨密度；铁是血红细胞形成的重要成分；锌有助于改善食欲。
Description
技术领域
本发明涉及乳品加工领域，具体是一种预防和降低高血压、血糖和血脂的奶粉。
背景技术
由于中老年人生理上的衰老和老化以及内脏器官、组织萎缩以及器官功能减退，中老年人消化吸收、代谢功能、排泄功能以及循环功能均有所减退，中老年人群是一些疾病的高发人群：中老年人能量消耗逐渐减少，蛋白质转化成氨基酸的速度明显变慢，糖代谢明显降低，由于组织可吸收和利用脂蛋白的减少，机体产生了清除障碍，导致血清中总胆固醇和甘油三酯随年龄增长而升高，这也是老年人易发高血脂的主要原因；中老年人的糖代谢明显降低，糖耐量也随年龄增高而下降，老年人糖耐量低，胰岛素分泌减少，且对血糖的调节作用减弱，因此血糖易增高；人体水分总量随年龄增高而减少，主要细胞内液减少，不能调控水平衡；细胞外液的钠和氯与细胞内液的钾、镁和磷的总量代谢不平衡，影响细胞渗透压及酸碱平衡，故老年人易发生脱水、水肿现象，又因老年人对口渴不敏感，故补充充足的水分很有必要；钙易沉着于软组织和动脉，导致硬化，产生骨质疏松现象，容易摔倒骨折；由于体内抗氧化防御系统减弱，导致老年人易患动脉粥样硬化、癌症、白内障等氧化损伤类疾病。因此确保老龄化人口的健康是一项重要任务。
奶粉是以生牛(羊)乳为原料，经加工制成的粉状产品，调制乳粉是以生牛(羊)乳或及其加工制品为主要原料，添加其它原料，添加或不添加食品添加剂和营养强化剂，经加工制成的乳固体含量不低于70％的粉状产品。设计科学营养健康且具有一定功能的针对中老年人群的配方奶粉，是解决其营养问题的最直接、有效方法。目前市场上缺乏专门针对中老年人群的配方奶粉，即使有，也存在实际服用效果欠佳，不能较好改善中老年人健康状况等问题。
发明内容
本发明的目的在于提供一种预防和降低高血压、血糖和血脂的奶粉，以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
一种预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉590-610、高油乳清粉295.8-299.8、低聚异麦芽糖77-83、碳酸钙5-9、粉末植物甾醇酯3-7、复配维生素1-3、牛磺酸0.8-1.2、复配矿物质0.8-1.2、Bb-12动物双歧杆菌0.08-0.12、鱼油粉0.8-1.2、苦瓜粉0.8-1.2、枸杞粉0.8-1.2、山楂粉0.8-1.2、南瓜粉0.8-1.2、山药粉0.8-1.2、乳铁蛋白0.08-0.12。
作为本发明进一步的方案：预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉600、高油乳清粉297.8、低聚异麦芽糖80、碳酸钙7、粉末植物甾醇酯5、复配维生素2、牛磺酸1、复配矿物质1、Bb-12动物双歧杆菌0.1、鱼油粉1、苦瓜粉1、枸杞粉1、山楂粉1、南瓜粉1、山药粉1、乳铁蛋白0.1。
作为本发明再进一步的方案：所述苦瓜粉、枸杞粉、山楂粉、南瓜粉以及山药粉分别为苦瓜含量不少于50％的苦瓜粉固体饮料、枸杞含量不少于50％的枸杞粉固体饮料、山楂原浆含量不少于50％山楂粉固体饮料、南瓜含量不少于50％的南瓜粉固体饮料、山药含量不少于50％的山药粉固体饮料。
作为本发明再进一步的方案：所述复配维生素由维生素A，维生素D，维生素E，维生素C组成，比例为1∶1∶15∶35∶48。
作为本发明再进一步的方案：所述复配矿物质由铁，锌和硒组成，比例为55∶44∶1
作为本发明再进一步的方案：所述高油乳清粉脱盐乳清粉和植物油组成，比例75∶25。
冲调及食用方法：
1)、先取45-55℃的温开水一杯180ml；
2)、量取5匙中老年奶粉，共25克放入温开水中；
3)、搅搅拌均匀后即可饮用；每日早晚各一杯。
鱼油粉
鱼油粉中含有二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)，DHA和EPA是两种多不饱和脂肪酸。
脂肪
减少脂肪 脂肪含量与全脂乳粉相比减少47％。
与现有技术相比，本发明的有益效果是：
本发明蛋白质是人体的主要构成物质并提供多种氨基酸；维生素A有助于维持皮肤和黏膜健康；维生素D可促进钙的吸收；维生素E有抗氧化作用；维生素C可以促进铁的吸收；钙是骨骼和牙齿的主要成分，并维持骨密度；铁是血红细胞形成的重要成分；锌有助于改善食欲。
具体实施方式
下面结合具体实施方式对本发明的技术方案作进一步详细地说明。
实施例1
一种预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉600、高油乳清粉297.8、低聚异麦芽糖80、碳酸钙7、粉末植物甾醇酯5、复配维生素2、牛磺酸1、复配矿物质1、Bb-12动物双歧杆菌0.1、鱼油粉1、苦瓜粉1、枸杞粉1、山楂粉1、南瓜粉1、山药粉1、乳铁蛋白0.1。
所述苦瓜粉、枸杞粉、山楂粉、南瓜粉以及山药粉分别为苦瓜含量不少于50％的苦瓜粉固体饮料、枸杞含量不少于50％的枸杞粉固体饮料、山楂原浆含量不少于50％山楂粉固体饮料、南瓜含量不少于50％的南瓜粉固体饮料、山药含量不少于50％的山药粉固体饮料。
所述复配维生素由维生素A，维生素D，维生素E，维生素C组成，比例为1∶1∶15∶35∶48。
所述复配矿物质由铁，锌和硒组成，比例为55∶44∶1
所述高油乳清粉脱盐乳清粉和植物油组成，比例75∶25。
冲调及食用方法：
1)、先取45-55℃的温开水一杯180ml；
2)、量取5匙中老年奶粉，共25克放入温开水中；
3)、搅搅拌均匀后即可饮用；每日早晚各一杯。
实施例2
一种预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉590、高油乳清粉295.8、低聚异麦芽糖77、碳酸钙5、粉末植物甾醇酯3、复配维生素1、牛磺酸0.8、复配矿物质0.8、Bb-12动物双歧杆菌0.08、鱼油粉0.8、苦瓜粉0.8、枸杞粉0.8、山楂粉0.8、南瓜粉0.8、山药粉0.8、乳铁蛋白0.08。
所述苦瓜粉、枸杞粉、山楂粉、南瓜粉以及山药粉分别为苦瓜含量不少于50％的苦瓜粉固体饮料、枸杞含量不少于50％的枸杞粉固体饮料、山楂原浆含量不少于50％山楂粉固体饮料、南瓜含量不少于50％的南瓜粉固体饮料、山药含量不少于50％的山药粉固体饮料。
所述复配维生素由维生素A，维生素D，维生素E，维生素C组成，比例为1∶1∶15∶35∶48。
所述复配矿物质由铁，锌和硒组成，比例为55∶44∶1
所述高油乳清粉脱盐乳清粉和植物油组成，比例75∶25。
冲调及食用方法：
1)、先取45-55℃的温开水一杯180ml；
2)、量取5匙中老年奶粉，共25克放入温开水中；
3)、搅搅拌均匀后即可饮用；每日早晚各一杯。
实施例3
一种预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉610、高油乳清粉299.8、低聚异麦芽糖83、碳酸钙9、粉末植物甾醇酯7、复配维生素3、牛磺酸1.2、复配矿物质1.2、Bb-12动物双歧杆菌0.12、鱼油粉1.2、苦瓜粉1.2、枸杞粉1.2、山楂粉1.2、南瓜粉1.2、山药粉1.2、乳铁蛋白0.12。
所述苦瓜粉、枸杞粉、山楂粉、南瓜粉以及山药粉分别为苦瓜含量不少于50％的苦瓜粉固体饮料、枸杞含量不少于50％的枸杞粉固体饮料、山楂原浆含量不少于50％山楂粉固体饮料、南瓜含量不少于50％的南瓜粉固体饮料、山药含量不少于50％的山药粉固体饮料。
所述复配维生素由维生素A，维生素D，维生素E，维生素C组成，比例为1∶1∶15∶35∶48。
所述复配矿物质由铁，锌和硒组成，比例为55∶44∶1
所述高油乳清粉脱盐乳清粉和植物油组成，比例75∶25。
冲调及食用方法：
1)、先取45-55℃的温开水一杯180ml；
2)、量取5匙中老年奶粉，共25克放入温开水中；
3)、搅搅拌均匀后即可饮用；每日早晚各一杯。
本发明的营养成分表：
| 项目 | 单位 | 每100g | NRV％ |
| 能量 | KJ | 1740 | 21％ |
| 蛋白质 | g | 20.0 | 33％ |
| 脂肪 | g | 11.2 | 19％ |
| 碳水化合物 | g | 58.0 | 19％ |
| 钠 | mg | 400 | 20％ |
| 维生素A | μgRE | 550 | 69％ |
| 维生素D | μg | 6.8 | 136％ |
| 维生素E | mgα-TE | 12.50 | 89％ |
| 维生素C | mg | 35.0 | 35％ |
| 钙 | mg | 750 | 94％ |
| 铁 | mg | 6.5 | 43％ |
| 锌 | mg | 3.7 | 25％ |
| 硒 | μg | 18.0 | 36％ |
| 牛磺酸 | mg | 33.0 | / |
| 乳铁蛋白 | mg | 7.0 | / |
上面对本发明的较佳实施方式作了详细说明，但是本发明并不限于上述实施方式，在本领域的普通技术人员所具备的知识范围内，还在不脱离本发明宗旨的前提下作出各种变化。
Claims (7)
1.一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，包含以下重量份的原料组成：脱脂乳粉590-610、高油乳清粉295.8-299.8、低聚异麦芽糖77-83、碳酸钙5-9、粉末植物甾醇酯3-7、复配维生素1-3、牛磺酸0.8-1.2、复配矿物质0.8-1.2、Bb-12动物双歧杆菌0.08-0.12、鱼油粉0.8-1.2、苦瓜粉0.8-1.2、枸杞粉0.8-1.2、山楂粉0.8-1.2、南瓜粉0.8-1.2、山药粉0.8-1.2、乳铁蛋白0.08-0.12。
2.根据权利要求1所述的一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，预防和降低高血压、血糖和血脂的奶粉，包含以下重量份的原料组成：脱脂乳粉600、高油乳清粉297.8、低聚异麦芽糖80、碳酸钙7、粉末植物甾醇酯5、复配维生素2、牛磺酸1、复配矿物质1、Bb-12动物双歧杆菌0.1、鱼油粉1、苦瓜粉1、枸杞粉1、山楂粉1、南瓜粉1、山药粉1、乳铁蛋白0.1。
3.根据权利要求1所述的一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，所述苦瓜粉、枸杞粉、山楂粉、南瓜粉以及山药粉分别为苦瓜含量不少于50％的苦瓜粉固体饮料、枸杞含量不少于50％的枸杞粉固体饮料、山楂原浆含量不少于50％山楂粉固体饮料、南瓜含量不少于50％的南瓜粉固体饮料、山药含量不少于50％的山药粉固体饮料。
4.根据权利要求1所述的一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，所述复配维生素由维生素A，维生素D，维生素E，维生素C组成，比例为1∶1∶15∶35∶48。
5.根据权利要求1所述的一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，所述复配矿物质由铁，锌和硒组成，比例为55∶44∶1。
6.根据权利要求1所述的一种预防和降低高血压、血糖和血脂的奶粉，其特征在于，所述高油乳清粉脱盐乳清粉和植物油组成，比例75∶25。
7.一种如权利要求1-2任一所述的一种预防和降低高血压、血糖和血脂的奶粉的冲调及食用方法，其特征在于，包括如下步骤：
1)、先取45-55℃的温开水一杯180ml；
2)、量取5匙中老年奶粉，共25克放入温开水中；
3)、搅搅拌均匀后即可饮用；每日早晚各一杯。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011462379.XA CN114617169A (zh) | 2020-12-10 | 2020-12-10 | 一种预防和降低高血压、血糖和血脂的奶粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011462379.XA CN114617169A (zh) | 2020-12-10 | 2020-12-10 | 一种预防和降低高血压、血糖和血脂的奶粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114617169A true CN114617169A (zh) | 2022-06-14 |
Family
ID=81895118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011462379.XA Pending CN114617169A (zh) | 2020-12-10 | 2020-12-10 | 一种预防和降低高血压、血糖和血脂的奶粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114617169A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114424788A (zh) * | 2020-10-29 | 2022-05-03 | 优菁元(黑龙江)营养食品科技有限公司 | 辅助稳定三高奶粉及生产用降膜式散蒸浓缩工艺和设备 |
| CN116173142A (zh) * | 2022-12-13 | 2023-05-30 | 郑涵 | 一种具有代谢调节功能的食药同源组方、药剂及制备方法 |
-
2020
- 2020-12-10 CN CN202011462379.XA patent/CN114617169A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114424788A (zh) * | 2020-10-29 | 2022-05-03 | 优菁元(黑龙江)营养食品科技有限公司 | 辅助稳定三高奶粉及生产用降膜式散蒸浓缩工艺和设备 |
| CN116173142A (zh) * | 2022-12-13 | 2023-05-30 | 郑涵 | 一种具有代谢调节功能的食药同源组方、药剂及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2477854C (en) | Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions | |
| CN111602720A (zh) | 一种中老年配方奶粉 | |
| CN106690290A (zh) | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 | |
| CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
| CN114617169A (zh) | 一种预防和降低高血压、血糖和血脂的奶粉 | |
| CN112655765A (zh) | 一种能延缓衰老、预防心脑血管疾病和糖尿病的奶粉配方 | |
| RU2525338C2 (ru) | Инстантный функциональный пищевой продукт | |
| JP4679687B2 (ja) | 肝機能改善剤 | |
| CN114947138A (zh) | 一种预防与改善钙缺乏病的乳钙组合物、其制法及应用 | |
| KR20060024766A (ko) | 혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품 | |
| KR20080103528A (ko) | 칼슘 흡수 촉진제 | |
| WO2005084661A1 (ja) | 抗腫瘍剤 | |
| RU2501285C1 (ru) | Низколактозный нежирный молочный продукт для геродиетического питания | |
| WO2019139032A1 (ja) | 癌患者筋肉量減少抑制組成物 | |
| JPH1014534A (ja) | 栄養組成物 | |
| CN101193647A (zh) | 有效减少脂肪的稳定的奶制品成分 | |
| CN104041553A (zh) | 一种适合中老年人食用的营养保健饼干 | |
| EP0824871B1 (en) | Process to obtain food compositions based on chufas (cyperus esculentus) and bananas, and compositions obtained | |
| CN112889921A (zh) | 一种儿童羊奶粉 | |
| RU2376781C1 (ru) | Пищевая эмульсия оздоровительного действия "крозам" и способ ее получения | |
| JPH1146720A (ja) | カルシウム吸収促進栄養組成物 | |
| KR20160010027A (ko) | 가르시아캄보지아(ｈｃａ)를 유효성분으로 함유하는 체지방 감소를 위한 조성물 | |
| CN114762509A (zh) | 一种具有改善心脑血管疾病的乳酸菌羊酸奶粉及制备方法 | |
| Murphy | Nutrients in food and how our body uses them | |
| RU1797476C (ru) | Способ приготовлени продукта лечебного питани |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220614 |